Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Ayus, J. C.
space
  arrow  Arieff, A. I.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

LETTER

Hyponatremia and Myelinolysis

right arrow J. Carlos Ayus, MD, and Allen I. Arieff, MD

15 July 1997 | Volume 127 Issue 2 | Page 163


TO THE EDITOR:

Drs. Laureno and Karp suggest that in humans, "rapid" correction of symptomatic hyponatremia may have detrimental sequelae, such as myelinolysis [1], despite overwhelming evidence to the contrary [2, 3]. Although absolute correction of hyponatremia in laboratory animals by more than 25 mmol/L in 48 hours can lead to cerebral demyelinating lesions, the "rate" of correction of plasma sodium concentrations in both humans and laboratory animals has been shown to be irrelevant [2, 4]. Most patients who have brain damage associated with hyponatremic encephalopathy are menstruant women who have had a hypoxic episode [4]. Among 117 patients with brain damage secondary to hyponatremic encephalopathy, 96% had a hypoxic episode secondary to delayed onset of therapy and only 4% had brain damage that might have been related to overcorrection [4]. In the past, the picture might have been distorted by the increased likelihood of brain damage after an increase of plasma sodium in patients with end-stage liver disease. The authors [1] unfortunately conclude that respiratory arrest leading to hypoxic encephalopathy in hyponatremic young women "rarely occurs," even though in the study they cite, most patients with hyponatremia were not included in the computer survey. To ascertain that most patients who have brain damage associated with hyponatremia are young women who have hypoxic events [4], the authors need look no further than Table 1 in the article by Steele and colleagues [5] in the same issue of Annals in which their review appears.

In summary, brain damage from hyponatremic encephalopathy due to delayed onset of therapy is at least 24 times more likely than brain damage due to improper therapy. Most patients who have brain damage secondary to hyponatremic encephalopathy are young (menstruant) women [4], whereas those who have brain damage from a change in plasma sodium concentration usually have end-stage liver disease.


Author and Article Information
space
up arrowTop
dotAuthor & Article Info
down arrowReferences

Baylor College of Medicine; Houston, TX 77024
University of California Medical Center; San Francisco, CA 94143
Request for Reprints: Robert H. Moser, MD, Canones Road, Box 616, Chama,NM 87520.


References
space
up arrowTop
up arrowAuthor & Article Info
dotReferences

1. Laureno R, Karp BI. Myelinolysis after correction of hyponatremia. Ann Intern Med. 1997; 126:57-62.

2. Sarnaik AP, Meert K, Hackbarth R, Fleischmann L. Management of hyponatremic seizures in children with hypertonic saline: a safe and effective strategy. Crit Care Med. 1991; 19:758-62.

3. Tien R, Arieff AI, Kucharczyk W, Wasik A, Kucharczyk J. Hyponatremic encephalopathy: is central pontine myelinolysis a component? Am J Med. 1992; 92:513-22.

4. Ayus JC, Arieff AI. Brain damage and postoperative hyponatremia: role of gender. Neurology. 1996; 46:323-8.

5. Steele A, Gowrishankar M, Abrahamson S, Mazer CD, Feldman RD, Halpern ML. Postoperative hyponatremia despite near-isotonic saline infusion: a phenomenon of desalination. Ann Intern Med. 1997; 126:20-5.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.





box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Ayus, J. C.
space
  arrow  Arieff, A. I.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online